Kaken Pharmaceutical Co., Ltd. (4521.T)
JPY 4192.0
(-2.58%)
JPY 4192.0
(-2.58%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 72.04 Billion | 72.98 Billion | 76.03 Billion | 74.97 Billion | 89.23 Billion | 94.16 Billion |
| Cost of Revenue | 33.82 Billion | 33.42 Billion | 34.45 Billion | 34.07 Billion | 38.75 Billion | 40.36 Billion |
| Gross Profit | 38.22 Billion | 39.55 Billion | 41.57 Billion | 40.9 Billion | 50.48 Billion | 53.8 Billion |
| Operating Expenses | 29.02 Billion | 31.55 Billion | 24.5 Billion | 23.11 Billion | 23.96 Billion | 29.2 Billion |
| Selling, General and Administrative Expenses | 16.16 Billion | 15.47 Billion | 15.83 Billion | 16.15 Billion | 17.32 Billion | 18.72 Billion |
| Research and Development Expenses | 12.54 Billion | 15.78 Billion | 8.42 Billion | 6.73 Billion | 6.41 Billion | 10.26 Billion |
| Other Expenses | 318 Million | 334 Million | 130 Million | 69 Million | 110 Million | 85 Million |
| Cost and Expenses | 62.53 Billion | 64.98 Billion | 58.96 Billion | 57.18 Billion | 62.71 Billion | 69.57 Billion |
| Operating Income | 9.51 Billion | 7.99 Billion | 17.06 Billion | 17.78 Billion | 26.51 Billion | 24.59 Billion |
| Interest Expense | 17 Million | 17 Million | 17 Million | 17 Million | 17 Million | 17 Million |
| Income Tax Expense | 1.77 Billion | 1.37 Billion | 4.33 Billion | 5.25 Billion | 7.22 Billion | 7.14 Billion |
| Earnings before Tax | 9.79 Billion | 6.81 Billion | 13.88 Billion | 18.65 Billion | 26.59 Billion | 24.92 Billion |
| Net Income | 8.02 Billion | 5.44 Billion | 9.54 Billion | 13.4 Billion | 19.37 Billion | 17.77 Billion |
| Earnings Per Share Basic | 212.66 | 144.79 | 251.44 | 347.37 | 494.89 | 445.78 |
| Earnings Per Share Diluted | 212.66 | 144.79 | 251.44 | 347.37 | 494.89 | 445.78 |
| Weighted Average Shares Outstanding | 37.73 Million | 37.57 Million | 37.97 Million | 38.59 Million | 39.14 Million | 39.87 Million |
| Weighted Average Shares Outstanding (Diluted) | 37.73 Million | 37.57 Million | 37.97 Million | 38.59 Million | 39.14 Million | 39.87 Million |
| Gross Margin | 0.53 | 0.54 | 0.55 | 0.55 | 0.57 | 0.57 |
| EBIT Margin | 0.17 | 0.16 | 0.26 | 0.27 | 0.33 | 0.29 |
| Profit Margin | 0.11 | 0.07 | 0.13 | 0.18 | 0.22 | 0.19 |
| EBITDA | 12.26 Billion | 10.56 Billion | 16.38 Billion | 20.1 Billion | 29.37 Billion | 27.19 Billion |
| Earnings Before Tax Margin | 0.13 | 0.11 | 0.22 | 0.24 | 0.30 | 0.26 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 18.25 Billion | 17.35 Billion | 72.04 Billion | 18.51 Billion | 18.02 Billion | 18.15 Billion |
| Cost of Revenue | 8.2 Billion | 8.68 Billion | 33.82 Billion | 8.37 Billion | 8.35 Billion | 8.09 Billion |
| Gross Profit | 10.05 Billion | 8.67 Billion | 38.22 Billion | 10.13 Billion | 9.66 Billion | 10.05 Billion |
| Operating Expenses | 7.3 Billion | 8.03 Billion | 28.7 Billion | 6.77 Billion | 7.44 Billion | 6.76 Billion |
| Selling, General and Administrative Expenses | 4.3 Billion | 3.99 Billion | - | 4.01 Billion | 4.3 Billion | 4.16 Billion |
| Research and Development Expenses | 2.99 Billion | 4.04 Billion | - | 2.76 Billion | 3.13 Billion | 2.6 Billion |
| Other Expenses | 1 Million | 25 Million | 57 Million | 15 Million | 15 Million | 2 Million |
| Cost and Expenses | 15.5 Billion | 16.71 Billion | 62.53 Billion | 15.15 Billion | 15.8 Billion | 14.85 Billion |
| Operating Income | 2.75 Billion | 640 Million | 9.51 Billion | 3.36 Billion | 2.21 Billion | 3.29 Billion |
| Interest Expense | 5 Million | 4 Million | 17 Million | 5 Million | 4 Million | 4 Million |
| Income Tax Expense | 617 Million | -775 Million | 1.77 Billion | 955 Million | 650 Million | 940 Million |
| Earnings before Tax | 2.37 Billion | 576 Million | 9.79 Billion | 3.56 Billion | 2.2 Billion | 3.45 Billion |
| Net Income | 1.75 Billion | 1.35 Billion | 8.02 Billion | 2.6 Billion | 1.55 Billion | 2.51 Billion |
| Earnings Per Share Basic | 46.32 | 35.65 | - | 68.84 | 41.29 | 66.98 |
| Earnings Per Share Diluted | 46.32 | 35.65 | - | 68.84 | 41.29 | 66.98 |
| Weighted Average Shares Outstanding | 37.86 Million | 37.86 Million | 37.73 Million | 37.86 Million | 37.73 Million | 37.47 Million |
| Weighted Average Shares Outstanding (Diluted) | 37.86 Million | 37.86 Million | 37.73 Million | 37.86 Million | 37.73 Million | 37.47 Million |
| Gross Margin | 0.55 | 0.50 | 0.53 | 0.55 | 0.54 | 0.55 |
| EBIT Margin | 0.19 | 0.08 | - | 0.19 | 0.12 | 0.19 |
| Profit Margin | 0.10 | 0.08 | 0.11 | 0.14 | 0.09 | 0.14 |
| EBITDA | 3.43 Billion | 1.31 Billion | - | 3.58 Billion | 2.23 Billion | 3.49 Billion |
| Earnings Before Tax Margin | 0.15 | 0.04 | 0.13 | 0.18 | 0.12 | 0.18 |
2310
ILU
0HTG
6005
0J3N
DXBRF